Information on commercial aspects of pharmacogenomics

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.4, Iss.6, 2003-11, pp. : 801-803

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

An information-driven approach to pharmacogenomics

By Vyas Hiten Summers Ron

Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. : 473-480

Future Medicine

Access to resources Recommend Favorite

Information management systems for pharmacogenomics

By Thallinger Gerhard G Trajanoski Slave Stocker Gernot Trajanoski Zlatko

Pharmacogenomics, Vol. 3, Iss. 5, 2002-09 ,pp. : 651-667

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics

Current Drug Metabolism, Vol. 9, Iss. 3, 2008-03 ,pp. : 207-212

Bentham Science Publishers

Access to resources Recommend Favorite

Candidate Genes in the Pharmacogenomics of Antihypertensive Treatment - A Review and Future Aspects

Current Pharmacogenomics, Vol. 2, Iss. 1, 2004-03 ,pp. : 83-112

Bentham Science Publishers

Access to resources Recommend Favorite

Commercial Aspects of Pharmaceutical Protein Production in Plants

Current Pharmaceutical Design, Vol. 19, Iss. 31, 2013-09 ,pp. : 5471-5477

Bentham Science Publishers

Access to resources Recommend Favorite